Keyuan Biological Bioskin in 2022 decreased by 68.03% year -on -year net profit of 5,104,100 yuan

On August 10, Keyuan Biological (Code: 873239.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 33.869 million yuan, a year-on-year decrease of 34.77%, and net profit was 5.1041 million yuan, a year-on-year decrease of 68.03%, and the basic earnings per share were 0.0800 yuan.

The company's industry is chemical products.

During the company's reporting period, the total assets at the end of the period were 220 million yuan, the operating profit was 5.6151 million yuan, the accounts receivable were 20.6326 million yuan, and the net cash flow generated by operating activities was -8.802 million yuan.The cash was 320.851 million yuan.

Keyuan Biological, the company, is called Jiangxi Keyuan Biological Co., Ltd., which was established on March 28, 2011. Liu Jianming, the current general manager, is the research and development, production and sales of tonsilic acid and derivative -related products.

- END -